Cost efficiency in the prospective diagnosis and follow-up of polyomavirus allograft nephropathy

Transplantation Proceedings

Volumn 36, Issue 10, 2004, Pages 3028-3031

  Drachenberg, C ^d   Hirsch, H H ^b   Papadimitriou, J C ^a   Mozafari, P ^a   Wali, R ^a   McKinney, J D ^a   Nogueira, J ^a   Cangro, C B ^a   Mendley, S ^a   Klassen, D K ^a   Ramos, Emilio ^a,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; FOLLOW UP; HUMAN; KIDNEY ALLOGRAFT; KIDNEY DISEASE; MAJOR CLINICAL STUDY; POLYOMA VIRUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING; URINE CYTOLOGY; VIREMIA; VIRUS LOAD; ALLOTRANSPLANTATION; BIOPSY; COST BENEFIT ANALYSIS; ECONOMICS; KIDNEY TRANSPLANTATION; PATHOLOGY; UNITED STATES; VIRUS INFECTION;

BIOPSY; COST-BENEFIT ANALYSIS; FOLLOW-UP STUDIES; HUMANS; KIDNEY TRANSPLANTATION; MARYLAND; POLYOMAVIRUS INFECTIONS; TRANSPLANTATION, HOMOLOGOUS; VIRAL LOAD; VIREMIA;

EID: 21244448487     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.10.045     Document Type: Article

References (14)

1. Dörries K: Latent and persistent polyomavirus infection. In: Khalili K, Stoner GL (eds), Human Polyomaviruses: Molecular and Clinical Perspectives. New York: Wiley-Liss; 2001, p 197
2. Hirsch HH, Steiger J: Polyomavirus BK. Lancet Infect Dis 3:611, 2003
3. Hirsch HH, Knowles W, Dickenmann M, et al: Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 347:488, 2002
4. Drachenberg CB, Beskow CO, Cangro CB, et al: Human polyomavirus in renal allograft biopsies: morphological findings and correlation with urine cytology. Hum Pathol 30:970, 1999
5. Agha IA, Brennan DC: BK virus and current immunosuppressive therapy. Graft 5:S65, 2002
6. Drachenberg RC, Drachenberg CB, Papadimitriou JC, et al: Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology. Am J Transplant 1:373, 2001
7. Randhawa P, Ho A, Shapiro R, et al: Correlates of quantitative measurements of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol 42:1176, 2004
8. Drachenberg CB, Papadimitriou JC, Hirsch HH, et al: Histological patterns of polyomavirus allograft nephropathy-correlation with outcome and viral load. Am J Transplant 4:2082, 2004
9. Hirsch HH, Brennan DC, Drachenberg CB, et al: Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations, (in preparation)
10. Ramos E, Drachenberg CB, Portocarrero M, et al: BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program, Clin Transpl 143, 2002
11. Drachenberg CB, Papadimitriou JC, Wali R, et al: Improved outcome of polyoma virus allograft nephropathy with early biopsy Transplant Proc. 36:758, 2004
12. Ramos E, Drachenberg CB, Papadimitriou JC, et al: Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 13:2145, 2002
13. Nickeleit V, Hirsch HH, Binet IF, et al: Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol 10:1080, 1999
14. Kazori A, Ducloux D, Chalopin JM, et al: The first case of JC virus allograft nephropathy. Transplantation 766:1653, 2003